• ftemx
• Mutual Fund
• International Stocks
• Emerging Markets

Fidelity® Total Emerging Markets Fund

Expenses: 1.14% (Better than 1% of similar funds)

This is a bad choice for a Emerging Markets International Stocks fund. See why »

• aemmx
• Mutual Fund
• International Stocks
• Emerging Markets

American Century Emerging Markets Fund A Class

Expenses: 1.50% (Better than 0% of similar funds)

This is a bad choice for a Emerging Markets International Stocks fund. See why »

• alvcx
• Mutual Fund
• US Stocks
• Large Value

American Beacon Large Cap Value Fund Class C

Expenses: 1.70% (Better than 0% of similar funds)

This is a bad choice for a Large Value US Stocks fund. See why »

• lngr
• ETF
• Sector Equity
• Healthcare

Global X Longevity Thematic ETF

Expenses: 0.50% (Better than 1% of similar funds)

This is a bad choice for a Healthcare Sector Equity fund. See why »

• amjix
• Mutual Fund
• Allocation
• All-In-One

American Century Multi-Asset Income Fund I Class

Expenses: 0.46% (Better than 1% of similar funds)

This is a bad choice for a All-In-One Allocation fund. See why »

• aqiix
• Mutual Fund
• International Stocks
• Large Blend

AQR International Equity Fund Class I

Expenses: 0.84% (Better than 1% of similar funds)

This is a bad choice for a Large Blend International Stocks fund. See why »

• bmgcx
• Mutual Fund
• US Stocks
• Mid-Cap Growth

BlackRock Mid-Cap Growth Equity Portfolio Investor C Shares

Expenses: 1.80% (Better than 0% of similar funds)

This is a bad choice for a Mid-Cap Growth US Stocks fund. See why »

• ayblx
• Mutual Fund
• Allocation
• All-In-One

Pioneer Balanced ESG Fund Class Y

Expenses: 0.69% (Better than 1% of similar funds)

This is a bad choice for a All-In-One Allocation fund. See why »

• bapdx
• Mutual Fund
• Allocation
• Target-Date

BlackRock LifePath® Smart Beta 2025 Fund Investor A Shares

Expenses: 0.32% (Better than 1% of similar funds)

This is a bad choice for a Target-Date Allocation fund. See why »

• bapex
• Mutual Fund
• Allocation
• Target-Date

BlackRock LifePath® Smart Beta 2030 Fund Investor A Shares

Expenses: 0.33% (Better than 1% of similar funds)

This is a bad choice for a Target-Date Allocation fund. See why »